SB 1574 (2022) -  Prescription Drug Price Transparency

by Cruz
Prohibiting permits for prescription drug manufacturers and nonresident prescription drug manufacturers and for certain wholesale distributors of prescription drugs from being renewed unless specified requirements are met; providing reporting requirements for certain entities that engage in wholesale distributions of prescription drugs; providing requirements for notifications by manufacturers of prescription drug price increases under certain circumstances; providing additional requirements for contracts between pharmacy benefit managers and individual health insurers, group health insurers, and health maintenance organizations, respectively, etc.
Effective Date: 07/01/2022
Last Event: 03/14/22 S Died in Banking and Insurance on Monday, March 14, 2022 1:02 PM

Referred Committees and Committee Actions

Senate Referrals

  • Banking and Insurance
  • Regulated Industries
  • Appropriations

Related Bills

Staff Analysis

(None Available)

Vote History

(No Votes Recorded)

Bill History

Event Time Member Committee Ver.
Event: S Died in Banking and Insurance Time: 03/14/2022 - 1:02 PM Member: Committee: Banking and Insurance Version: __
Event: S Indefinitely postponed and withdrawn from consideration Time: 03/12/2022 - 12:00 AM Member: Committee: Version: __
Event: S Introduced -SJ 136 Time: 01/18/2022 - 4:22 PM Member: Committee: Version: __
Event: S Referred to Banking and Insurance; Regulated Industries; Appropriations -SJ 136 Time: 01/12/2022 - 11:32 AM Member: Committee: Banking and Insurance Version: __
Event: S Filed Time: 01/06/2022 - 8:19 AM Member: Committee: Version: __